It might be possible to get the all-but-miraculous medicine ‘smart drugs’ in the U.S. this week

(Updated at 3:40 p.m.) The Food and Drug Administration could approve Moderna Therapeutics’s boosters for adult patients as early as this week. The drug company on Thursday asked the FDA to allow approval of…

It might be possible to get the all-but-miraculous medicine ‘smart drugs’ in the U.S. this week

(Updated at 3:40 p.m.) The Food and Drug Administration could approve Moderna Therapeutics’s boosters for adult patients as early as this week.

The drug company on Thursday asked the FDA to allow approval of the therapies, which are meant to improve the protein-replacement therapy Moderna’s drug Onexanabin is used to. An FDA team held a meeting Friday to consider the request.

If approved, Moderna would be the first drug company to have its boosters, which have been nicknamed “smart drugs,” sold for adult patients.

Long-lasting medicines that mimic the beneficial effects of nature, such as omega-3 fatty acids and folic acid supplements, are increasingly being sold for patients with chronic diseases like Parkinson’s, Alzheimer’s and asthma. But those treatments have proved so effective that they can sometimes erase the need for patients to take pills.

Moderna’s boosters build on the same technology, circulating patients’ insulin through the bloodstream.

The FDA declined to give a date for a decision on the boosters’ approval.

According to Moderna, Onexanabin, the therapy, is only targeted at those with Type 1 or Type 2 diabetes, with no requirement for patients to take the supplements.

More than 90 percent of people with Type 1 diabetes are diagnosed before age 18, and the disease grows with age, according to Moderna.

People with Type 1 diabetes, are the most common type of diabetes, and it can cause blindness, amputations and stroke.

Moderna is not a manufacturer of the supplement, but it is developing other therapies aimed at diabetes and cardiovascular conditions.

Moderna says many of the boosters in its clinical trial will be sold to pharmaceutical companies.

The boosters are expected to cause blood sugar to dip slightly in a person’s blood, according to Moderna, and the medicine should gradually lead to a gradual boost in blood sugar and insulin.

There are no approved drugs or supplements that can mimic that effect, however.

Leave a Comment